|
|
||||||||
|
|
|||||||||
|
|
Radiopharmaceutical Chemistry: New Chemistry-OtherNew Chemistry-Other Posters |
1 Division of Nuclear Medicine and RI Application, KIRAMS, Seoul, South Korea
1293
Objectives: Annexin V labeled with radioisotope and optical probe has been used to detect apoptosis. To evaluate annexin V as a multimodal apoptosis image agent, large-scale preparation of Annexin V (AV) is prerequisite. The aim of this study is to produce and purify recombinant human Annexin V (rh-AV) in E. coli system and to evaluated radiolabeled rh-AV in vitro and in vivo apoptosis model system.
Methods: Annexin V cDNA was obtained from human placenta and rh-AV cloned in E. coli pET 28a (+) vector, expressed and purified by His-Tag and T7-Tag resins. In camptothecin induced Jurkat T cell apoptosis model, AV-PI flow cytometry analysis and in vitro binding assay of I-124 rh-AV were performed and compared. Biodistributions and small animal PET images of I-124 AV and rh-AV were evaluated and compared in normal and Fas-madiated hepatic apoptosis Balb/c mice models.
Results: Through two step purification process, rh-AV showed 35 Kd single band in SDS-PAGE. As camptothecin concentration increasing, AV-FITC positive % increased in flow cytometry analysis and uptake of I-124 rh-AV also increased. AV-FITC positive % was correlated with and uptake of I-124 rh-AV (R2=0.99). I-124 rh-AV showed faster blood clearance and lower non specific uptake (liver and kidney) than I-124 AV. In Fas-mediated hepatic apoptosis model, I-124 rh-AV (3.8 %ID/g) was more selectively localized in liver region of PET image than I-124 AV (3.49 %ID/g).
Conclusions: Recombinant Human annexin V was produced by E. coli system and purified using two step affinity chromatography. Radiolabeled rh-AV was useful for the evaluation of apoptosis in vitro and in vivo model. Recombinant human annexin V could be used as apoptosis imaging agent with various radiolabel and optical probe.
| ||||||||||||||||||||||||||||||||||||||